The propofol-sparing effect of intravenous lidocaine in patients undergoing colonoscopy with bispectral index monitoring. bispectral index, colonoscopy, lidocaine, monitoring, propofol
Conditions
Interventions
Lidocaine 1.5 mg/kg iv bolus then infusion 4 mg/kg/h,Normal saline bolus and infusion
Experimental Drug,Placebo Comparator No treatment
Sponsors
Phramongkutklao hospital
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 20 to 80 years 2. American Society of Anesthesiologists physical status I-III
Exclusion criteria
Exclusion criteria: 1. Severe cardiovascular and pulmonary diseases 2. Liver or renal insufficiency 3. Mental disorders 4. language barrier 5. history of colectomy 6. history of being allergic to lidocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total dosage of intravenous propofol At the end of the operation Milligram of propofol | — |
Secondary
| Measure | Time frame |
|---|---|
| a comparison of hemodynamic variations, episodes of oxygen desaturation, the duration of full consciousness and prompt response to the PACU, the sedative level , patient satisfaction, pain score Within 60 minutes in the recovery room Verbal numerical rating score (VNRS), blood pressure and oxygen saturation percent changes, patient satisfaction, BIS | — |
Countries
Thailand
Contacts
Public ContactKrisana Nongnuang
Phramongkutkal hospitsl
Outcome results
None listed